{"id":"W4386270971","doi":"10.1016/s2152-2650(23)00760-7","title":"POSTER: IBCL-098 TRANSCEND FL: Phase II Study Results of Lisocabtagene Maraleucel (Liso-Cel) in Patients With R/R Follicular Lymphoma (FL)","year":2023,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Princess Margaret Cancer Centre","funders":"University of Texas MD Anderson Cancer Center; School of Medicine, Stanford University; Centre hospitalier régional universitaire de Lille; Washington University School of Medicine in St. Louis; University College London Hospitals NHS Foundation Trust; Universität zu Köln; Massachusetts General Hospital; Hokkaido University; Bristol-Myers Squibb; Centro de Investigación Biomédica en Red de Cáncer; Medizinische Universität Wien; Karolinska Institutet; Memorial Sloan-Kettering Cancer Center; Universität Wien; University College London","keywords":"Follicular lymphoma; Follicular phase; Oncology; Medicine; Internal medicine; Biology; Lymphoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009197767,0.001079932,0.001070592,0.0002943846,0.000324055,0.0009415608,0.0007593145,0.001219596,0.0147659],"category_scores_gemma":[0.0006729641,0.0003389428,0.00114433,0.0001805747,0.0005198707,0.0005570146,0.0002962626,0.00326826,0.003199846],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000653486,"about_ca_system_score_gemma":0.0007714134,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001200674,"about_ca_topic_score_gemma":0.002805075,"domain_scores_codex":[0.9997879,0.00008303959,0.00001008802,0.00003408822,0.0000218093,0.00006304902],"domain_scores_gemma":[0.9995889,0.00007930771,0.00004604916,0.00002384101,0.00002887991,0.0002330986],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.3955375,0.0299083,0.004907972,0.001939867,0.002118279,0.0005445128,0.000310746,0.001939722,0.04931242,0.0008617913,0.08106766,0.4315512],"study_design_scores_gemma":[0.4957588,0.398407,0.02577466,0.0003439059,0.001751551,0.001039026,0.0001640529,0.001741364,0.01099257,0.0005861378,0.06334147,0.00009948595],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8982387,0.04206248,0.001919204,0.01083066,0.002916702,0.002545298,0.007603894,0.0009164698,0.03296659],"genre_scores_gemma":[0.9411615,0.01337566,0.00281717,0.005582784,0.001161907,0.001081125,0.007714111,0.0001642755,0.0269414],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0147659,"threshold_uncertainty_score":0.04939681,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02781592921887291,"score_gpt":0.3251656614464571,"score_spread":0.2973497322275842,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}